News

Everyone is looking forward to the arrival of the vaccine for the novel coronavirus. However, when the vaccine is ready, a fast, reliable and safe logistics process is made necessary. This will ensure successful immunization results. One of the key questions related to vaccines is the importance of temperature maintenance specified by the manufacturer during storage and transportation. In Brazil, Anvisa published a resolution that changes the standard on Good Drug Product Distribution, Storage and Transportation Practices.

See full article.

BLS Tech has monitoring solutions ready to meet new Anvisa resolution for transportation of drug products and vaccines.

See full article.

BLS Tech has monitoring solutions ready to meet new Anvisa resolution for transportation of drug products and vaccines.

See full article.

BLS Tech has solutions ready to meet new Anvisa resolution for transportation.

The logistics sector for cold chain has been considerably impacted in the past months in view of the new resolutions of the Brazilian Health Regulatory Agency (Anvisa) for distribution of Covid-19 vaccines and pharmaceutical products. With wide experience in the sector, BLS Tech (Biothermal Logistics Solutions), first logtech integrating solutions 100% focused on cold chain, already provides solutions and know-how in the entire process.

See full article.

Carine Siffert, BLS Quality Manager, was responsible for the speech of Abralog’s monthly Logistics Committee, this Thursday, 06/10/2021. The goal of the presentation was to show the overview of RDC 430/2020, standard that determines the obligation of monitoring, control and temperature maintenance across the supply chain, as per manufacturer specifications.

See full article.

The cold chain webinar is scheduled for next week

See full article.

BLS Tech solutions meet RDC 430 standards, says the company CEO.

See full article

Dedicated to health cold chain, BLS is joins Abralog for cutting edge logistics

INTERVIEW FÁBIO MARTINS | BLS CEO

Expert in innovation, distribution and release of products in pharmaceutical and cold chain industry, Fábio Martins, CEO and founding partner of BLS Pelican, will tell us on this interview everything about this company, which has just joined Abralog. Martins has over 25 years of experience in B2B markets, including multinationals such as Schering-Plough, Ranbaxy and Glenmark, and took part of start-up of the latter two in Brazil, Argentina, Mexico, Colombia and Peru.

See full article